Trial NCT01754623

View at ClinicalTrials.gov 
Org. Study IDs: MCC-16932

Last trial update was posted on 2015-08-13

MeSH Interventions

Capecitabine Docetaxel Fluorouracil Gemcitabine

MeSH Conditions

Pancreatic Neoplasms

Other Conditions

Pancreatic Cancer

Stopping Reasons

Lack of pre-treatment tissue to make the study plan feasible.

Limitations And Caveats

The study only accrued 9 (of planned 35) participants. It was not possible to collect adequate pre-treatment tissue for radiosensitivity index (RSI) analysis, pre-treatment. The study was terminated before planned completion.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID